Alteration in frequency and function of CD4+CD25 +FOXP3+ regulatory T cells in patients with immune thrombocytopenic purpura

Iranian Journal of Allergy, Asthma and Immunology

Volumn 13, Issue 2, 2014, Pages 85-92

  Arandi, Nargess ^a   Mirshafiey, Abbas ^a   Jeddi Tehrani, Mahmood ^b   Shaghaghi, Mohammadreza ^c   Sadeghi, Bamdad ^c   Abolhassani, Hassan ^c   Sharifian, Ramazan Ali ^a   Rahiminejad, Mohammad Saeid ^a   Aghamohammadi, Asghar ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AVICENNA RESEARCH INSTITUTE   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Immune thrombocytopenic purpura (ITP); Regulatory T cells (Trges); Suppressive function

Indexed keywords

CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GENE FREQUENCY; HOMEOSTASIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE;

ADOLESCENT; ADULT; CD4 LYMPHOCYTE COUNT; CHILD; CTLA-4 ANTIGEN; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-10; MALE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84897953554     PISSN: 17351502     EISSN: 17355249     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 2012; 30:531-64.
2. Romagnoli P, van Meerwijk JPM. Thymic Selection and Lineage Commitment of CD4+ Foxp3+ Regulatory T Lymphocytes. Prog Mol Biol Transl Sci 2010; 92:251-77.
3. Mottet C, Golshayan D. CD4+CD25+Foxp3+ regulatory T cells: from basic research to potential therapeutic use. Swiss Med Wkly 2007; 137(45-46):625-34. (Pubitemid 350189579)
4. Toda A, Piccirillo CA. Development and function of naturally occurring CD4+CD25+ regulatory T cells. J Leukoc Biol 2006; 80(3):458-70. (Pubitemid 44835778)
5. Barreto M, Ferreira RC, Lourenco L, Moraes-Fontes MF, Santos E, Alves M, et al. Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants. BMC Immunol 2009; 10:5.
6. Bonelli M, Savitskaya A, von Dalwigk K, Steiner CW, Aletaha D, Smolen JS, et al. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int Immunol 2008 Jul; 20(7):861-8. (Pubitemid 351876312)
7. Crispin JC, Martinez A, Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2003; 21(3):273-6. (Pubitemid 37410115)
8. Saruta M, Yu QT, Fleshner PR, Mantel PY, Schmidt-Weber CB, Banham AH, et al. Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease. Clin Immunol 2007; 125(3):281-90. (Pubitemid 350123608)
9. Venigalla RK, Tretter T, Krienke S, Max R, Eckstein V, Blank N, et al. Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 - /low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum 2008; 58(7):2120-30. (Pubitemid 351988104)
10. Xu WH, Zhang AM, Ren MS, Zhang XD, Wang F, Xu XC, et al. Changes of Treg-Associated Molecules on CD4(+)CD25 (+)Treg Cells in Myasthenia Gravis and Effects of Immunosuppressants. J Clin Immunol 2012; 32(5):975-83.
11. Cines DB, Bussel JB, Liebman HA, Prak ETL. The ITP syndrome: pathogenic and clinical diversity. Blood 2009; 113(26):6511-21.
12. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010; 115(2):168-86.
13. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009; 113(11):2386-93.
14. Semple JW, Provan D. The immunopathogenesis of immune thrombocytopenia: T cells still take center-stage. Curr Opin Hematol 2012; 19(5):357-62.
15. Zhou B, Zhao H, Yang RC, Han ZC. Multi-dysfunctional pathophysiology in ITP. Crit Rev Oncol Hematol 2005; 54(2):107-16. (Pubitemid 40544948)
16. Ware RE, Howard TA. Phenotypic and clonal analysis of T lymphocytes in childhood immune thrombocytopenic purpura. blood 1993; 82(7):2137-42.
17. Panitsas FP, Theodoropoulou M, Kouraklis A, Karakantza M, Theodorou GL, Zoumbos NC, et al. Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. blood 2004; 103(7):2645-7.
18. Semple JW, Milev Y, Cosgrave D, Mody M, Hornstein A, Blanchette V, et al. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. blood 1996; 87(10):4245-54.
19. Wang T, Zhao H, Ren H, Guo J, Xu M, Yang R, et al. Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura. Haematologica 2005; 90(7):914-23. (Pubitemid 41020294)
20. Liu B, Zhao H, Poon MC, Han Z, Gu D, Xu M, et al. Abnormality of CD4+ CD25+ regulatory T cells in idiopathic thrombocytopenic purpura. Eur J Haematol 2006; 78(2):139-43.
21. Sakakura M, Wada H, Tawara I, Nobori T, Sugiyama T, Sagawa N, et al. Reduced Cd4+ Cd25+ T cells in patients with idiopathic thrombocytopenic purpura. Thromb Res 2007; 120(2):187-93. (Pubitemid 46754414)
22. Yu J, Heck S, Patel V, Levan J, Yu Y, Bussel JB, et al. Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura. Blood 2008; 112(4):1325-8.
23. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155(3):1151-64.
24. Wei S, Kryczek I, Zou W. Regulatory T-cell compartmentalization and trafficking. Blood 2006; 108(2):426-31. (Pubitemid 44061338)
25. Wan YY, Flavell RA. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007; 445(7129):766-70. (Pubitemid 46279706)
26. Yurchenko E, Shio MT, Huang TC, Da Silva Martins M, Szyf M, Levings MK, et al. Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo. PLoS One 2012; 7(4):e35572.
27. Ermann J, Fathman CG. Costimulatory signals controlling regulatory T cells. Proc Natl Acad Sci U S A 2003; 100(26):15292-3. (Pubitemid 38020981)
28. Andre S, Tough DF, Lacroix-Desmazes S, Kaveri SV, Bayry J. Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications. Am J Pathol 2009; 174(5):1575-87.
29. Nocentini G, Riccardi C. GITR: a modulator of immune response and inflammation. Adv Exp Med Biol 2009; 647:156-73.
30. Shevach EM, Stephens GL. The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nat Rev Immunol 2006; 6(8):613-8. (Pubitemid 44134094)
31. Andersson PO, Olsson A, Wadenvik H. Reduced transforming growth factor-β1 production by mononuclear cells from patients with active chronic idiopathic thrombocytopenic purpura. Br J Haematol 2002; 116(4):862-7. (Pubitemid 34227008)
32. Catani L, Sollazzo D, Trabanelli S, Curti A, Evangelisti C, Polverelli N, et al. Decreased expression of indoleamine 2, 3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia. Ann Hematol 2013; 92(1):67-78.
33. Fujio K, Okamura T, Yamamoto K. The Family of IL-10-Secreting CD4+ T Cells. Adv Immunol 2010; 105:99-130.
34. Bridoux F, Badou A, Saoudi A, Bernard I, Druet E, Pasquier R, et al. Transforming Growth Factor β (TGF-β)-dependent Inhibition of T Helper Cell 2 (Th2)-induced Autoimmunity by Self-Major Histocompatibility Complex (MHC) Class II-specific, Regulatory CD4+ T Cell Lines. Journal Exp Med 1997; 185(10):1769-75. (Pubitemid 27242198)
35. Cross D, Cambier JC. Transforming growth factor beta 1 has differential effects on B cell proliferation and activation antigen expression. J Immunol 1990; 144(2):432-9. (Pubitemid 20036066)